Bruno Ali López Luis

ORCID: 0000-0003-1242-1059
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • Bacterial Identification and Susceptibility Testing
  • Infective Endocarditis Diagnosis and Management
  • Antibiotic Use and Resistance
  • Antibiotic Resistance in Bacteria
  • COVID-19 and healthcare impacts
  • Hepatitis C virus research
  • Hepatitis B Virus Studies
  • Tuberculosis Research and Epidemiology
  • Mycobacterium research and diagnosis
  • Infectious Diseases and Mycology
  • Pneumothorax, Barotrauma, Emphysema
  • Rheumatoid Arthritis Research and Therapies
  • Infectious Diseases and Tuberculosis
  • Poxvirus research and outbreaks
  • Immunodeficiency and Autoimmune Disorders
  • Orthopedic Infections and Treatments
  • HIV/AIDS drug development and treatment
  • Infections and bacterial resistance
  • Bacillus and Francisella bacterial research
  • Inflammatory Bowel Disease
  • Antimicrobial Resistance in Staphylococcus
  • Parasitic infections in humans and animals
  • Pleural and Pulmonary Diseases

Institute for Social Security and Services for State Workers
2025

Centro Medico Nacional Siglo XXI
2022-2023

Centro Médico Nacional La Raza
2022-2023

Hospital de Especialidades
2022-2023

Mexican Social Security Institute
2019-2022

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
2017-2022

Hospital General Dr. Manuel Gea Gonzalez
2022

Hospital General De Zona
2019-2022

Universidad Nacional Autónoma de México
2022

Donostia Unibertsitate Ospitalea
2021

We sought to identify risk factors associated with vancomycin-resistant Enterococcus faecium (VRE) and ampicillin-resistant faecalis (ARE) bacteraemia, predictors of 30-day mortality, 90-day recurrence-free survival according resistance. evaluated clinical records patients E. bacteraemia (2007-2017). performed bivariate multivariate logistic regression analyses VRE ARE mortality. A Kaplan-Meier estimate was done. identified 192 147 episodes, respectively, which 55.7% were (94% vanA) 12.2%...

10.1016/j.jgar.2020.12.005 article EN cc-by-nc-nd Journal of Global Antimicrobial Resistance 2020-12-25

Nontuberculous mycobacteria (NTM) comprise several pathogens with a complex profile of virulence, diverse epidemiological and clinical patterns as well host specificity. Recently, an increase in the number NTM infections has been observed; therefore, objective this study was to evaluate characteristics outcomes these infections. We included patients between 2001–2017 obtained risk factors, features outcomes; finally, we compared data slowly growing (SGM) rapidly (RGM). A total 230 were...

10.1016/j.bjid.2020.04.012 article EN cc-by-nc-nd The Brazilian Journal of Infectious Diseases 2020-05-01

We aimed to describe the use of drugs with apparent efficacy in ambulatory patients confirmed COVID-19 and relationship Google Trends searches prescriptions total number cases Mexico City.Between March 2020 February 2021, we surveyed 350 have across 3 hospitals City for their prescriptions. analysed correlation between prescription patterns 4 against COVID-19, these drugs, overall City.We included patients, whom 59% were women a median age 38 years (interquartile range, 29-51), 72% had...

10.1093/fampra/cmab167 article EN Family Practice 2021-12-03

We aimed to assess the factors associated with 30-day mortality in patients vancomycin-resistant Enterococcus faecium (VREf) bloodstream infection (BSI) who received treatment linezolid an 11-year retrospective cohort of VREf BSI. A univariate and stepwise multivariate logistic regression analysis was performed determine factors. Moreover, a Cox proportional hazards predictor covariates performed. Eighty were included final analysis; 42 (53%) died 38 (47%) survived 30 days after index...

10.1089/mdr.2021.0333 article EN Microbial Drug Resistance 2022-03-25

Mycobacterium obuense is a pigmented, rapidly growing mycobacterium. Because it has been considered nonpathogenic, M. being investigated in clinical trials of cancer immunotherapy and bioremediation. We report case bacteremia caused by patient with pneumonia, showing its potential pathogenicity.

10.3201/eid2505.180208 article EN cc-by Emerging infectious diseases 2019-03-14

Objective: We aimed to evaluate the frequency and associated factors of baseline NS5A resistance-associated substitutions (RASs) in patients coinfected with human immunodeficiency virus (HIV) hepatitis C (HCV) monoinfection genotype 1b (GT1b) or 1a (GT1a). Moreover, we performed a phylogenetic analysis pattern clustering among samples RASs. Results: Fifty-five were infected GT1a, whom 44 (80%) HIV-infected patients. RAS prevalence GT1a was 14% (6/44) distributed as follows: 5 (11%) harbored...

10.1089/mdr.2020.0436 article EN Microbial Drug Resistance 2021-04-01

The recent detection of hepatitis C virus genotype 4 infection in human immunodeficiency virus-infected patients prompted performing molecular characterization these isolates. All the Mexican isolates belonged to a subcluster within 4d group and shared common ancestor with French isolate. estimated timing introduction Mexico City was as December 2015.

10.1097/olq.0000000000001596 article EN Sexually Transmitted Diseases 2022-01-10

Introduction: International guidelines recommend hospital care for patients with severe Coronavirus disease (COVID-19), but fragile health systems struggle to cope high number of admissions, placing at risk receiving substandard care. We describe an outpatient ambulatory surveillance and treatment strategy (OPAT) workers (HCWs) COVID-19 during low bed availability periods in Mexico City. Methods: In this observational, descriptive, retrospective study, we included HCWs whom there were no...

10.1177/20499361221130212 article EN cc-by-nc Therapeutic Advances in Infectious Disease 2022-01-01
Coming Soon ...